PubMed Summary

Title Average Ratingsort ascending
Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. 70.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glyc 60.00%
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer. 60.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
Tolerance to the anticonvulsant effect of morphine in mice: blockage by ultra-low dose naltrexone. 60.00%
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of 60.00%
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. 60.00%
1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising.. 60.00%
Anti-angiogenic therapies for metastatic colorectal cancer. 60.00%
The influence of the novel drug Ukrain on hemo- and immunopoiesis at the time of its maximum radioprotective effect 60.00%
Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and 60.00%
Clinical studies of Ukrain in healthy volunteers (phase 1). 60.00%
The oil-dispersion bath in Anthroposophic Medicine - an integrative review. 60.00%
Unconventional anticancer agents: a systematic review of clinical trials. 60.00%
Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses? 60.00%
Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during sh 60.00%
Pycnogenol may alleviate adverse effects in oncologic treatment. 60.00%
A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients wi 60.00%
Strong synergy of heat and modulated electromagnetic field in tumor cell killing. 60.00%
Complete remission of psoriasis following bevacizumab therapy for colon cancer. 60.00%
Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal...... 60.00%
Primary melanocytic tumor of the cerebellopontine angle mimicking a vestibular schwannoma: case report. 60.00%
Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. 60.00%
Increased Response to Ketamine Following Treatment at Long Intervals: Implications for Intermittent Use. 60.00%
Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate 60.00%
Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy 60.00%
Serum calcium and the risk of prostate cancer. 60.00%
Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma. 60.00%
Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest. 60.00%
Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report) 60.00%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Vitamin D and prostate cancer risk: a review of the epidemiological literature. 60.00%
Beta-solamarine: tumor inhibitor isolated from Solanum dulcamara. 60.00%
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells 60.00%
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder 60.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
Systematic review of the treatment of cancer-associated anorexia and weight loss. 60.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Does the Ukrain preparation protect mice against lethal doses of bacteria? 60.00%
Preliminary studies on the effect of Ukrain on the immunological response in patients with malignant tumours. 60.00%
Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angio.. 60.00%
A case of metronomic chemotherapy as an alternative cancer therapy for palliation 60.00%
The association between degenerative hip joint pathology and size of the gluteus medius, gluteus minimus and piriformis muscles. 60.00%
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo 60.00%
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) 60.00%
Theoretical grounds and experimental confirmation of the antiviral effect of the 60.00%
Tumor pO(2) as a Surrogate Marker to Identify Therapeutic Window during Metronomic Chemotherapy of 9L Gliomas. 60.00%
Review on molecular and therapeutic potential of thymoquinone in cancer. 60.00%
Early outcomes following low dose naltrexone enhancement of opioid detoxification. 60.00%
Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase path-- 60.00%
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. 60.00%
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice 55.00%
Removed from Pubmed because of suspicion of scientific fraud: Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). 55.00%
Alert because of Scientific Fraud: Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). 55.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid 55.00%
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal 50.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer. 50.00%
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer 50.00%
Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment? 50.00%
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase 50.00%
A study of the influence of a novel drug Ukrain on in vivo effects of low-dose ionizing radiation 50.00%
Six-week treatment with Ukrain in rabbits. Part I: Morphological parameters 50.00%
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line 50.00%
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, 50.00%
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer 50.00%
Five novel mono-tetrahydrofuran ring acetogenins from the seeds of Annona muricata. 50.00%
Ukrain (NSC-631570) influences on bone status: a review. 50.00%
Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. 50.00%
A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study 50.00%
Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain 50.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u 50.00%
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. 50.00%
Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. 50.00%
Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin.... 50.00%
A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. 50.00%
Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in 50.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Roles of sildenafil in enhancing drug sensitivity in cancer. 50.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary 50.00%
Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. 50.00%
Case report of a pituitary macroadenoma treated with artemether. 50.00%
Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation. 50.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Biological activity of some thiophosphamide derivatives of alkaloids with respect to influenza virus 50.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin.... 50.00%
Inhibition of angiogenesis by non-toxic doses of temozolomide. 50.00%
WITHDRAWN: Ovarian ablation for early breast cancer. 50.00%
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. 50.00%
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. 50.00%
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide. 50.00%
Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and 50.00%
Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured gliobl 50.00%
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryother 50.00%
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors. 50.00%
Chemoradiotherapy in malignant glioma: standard of care and future directions. 50.00%

Pages